Outcomes From Treating Tuberculosis With Rifampicin or Rifabutin in HIV-Infected Persons Also Receiving Antiretroviral Therapy

被引:0
|
作者
Rawson, Timothy M. [1 ]
Brima, Nataliya [2 ]
Almajid, Fahad [3 ]
Pozniak, Anton L. [3 ]
Janmohamed, Azara [4 ]
Mandalia, Sundhiya [1 ,3 ]
Basnayake, Sheena [3 ]
Kellgren, Lusha [4 ]
Copas, Andrew J. [2 ]
Miller, Robert F. [2 ,4 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] UCL, Res Dept Infect & Populat Hlth, London, England
[3] Chelsea & Westminster Hosp NHS Fdn Trust, St Stephens Ctr, London, England
[4] Univ Coll London Hosp NHS Fdn Trust, TB Serv, London, England
关键词
DRUG-INTERACTIONS; COMBINATION; RESISTANCE; RELAPSE;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:E84 / E87
页数:4
相关论文
共 50 条
  • [1] Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa
    Komati, Stephanus
    Shaw, Pamela A.
    Stubbs, Nomso
    Mathibedi, Monkwe J.
    Malan, Lizette
    Sangweni, Phumelele
    Metcalf, Julia A.
    Masur, Henry
    Hassim, Shaheen
    [J]. AIDS, 2010, 24 (12) : 1849 - 1855
  • [2] Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
    Dean, GL
    Edwards, SG
    Ives, NJ
    Matthews, G
    Fox, EF
    Navaratne, L
    Fisher, M
    Taylor, GP
    Miller, R
    Taylor, CB
    de Ruiter, A
    Pozniak, AL
    [J]. AIDS, 2002, 16 (01) : 75 - 83
  • [3] IMPACT OF TUBERCULOSIS ON MORTALITY AMONG HIV-INFECTED PATIENTS RECEIVING ANTIRETROVIRAL THERAPY
    Chu, R.
    Mills, E.
    Beyene, J.
    Bakanda, C.
    Nachega, J.
    Thabane, L.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S73 - S73
  • [4] Pharmacokinetics of Rifabutin in Japanese HIV-Infected Patients with or without Antiretroviral Therapy
    Tanuma, Junko
    Sano, Kazumi
    Teruya, Katsuji
    Watanabe, Koji
    Aoki, Takahiro
    Honda, Haruhito
    Yazaki, Hirohisa
    Tsukada, Kunihisa
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    [J]. PLOS ONE, 2013, 8 (08):
  • [5] Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin
    Manosuthi, W
    Sungkanuparph, S
    Thakkinstian, A
    Vibhagool, A
    Kiertiburanakul, S
    Rattanasiri, S
    Prasithsirikul, W
    Sankote, J
    Mahanontharit, A
    Ruxrungtham, K
    [J]. AIDS, 2005, 19 (14) : 1481 - 1486
  • [6] Gynecomastia in HIV-infected patients receiving antiretroviral therapy
    García-Benayas, T
    Blanco, F
    Martín-Carbonero, L
    Valencia, E
    Barrios, A
    González-Lahoz, J
    Soriano, V
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (09) : 739 - 741
  • [7] Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy
    Girardi, E
    Antonucci, G
    Vanacore, P
    Palmieri, F
    Matteelli, A
    Iemoli, E
    Carradori, S
    Salassa, B
    Pasticci, MB
    Raviglione, MC
    Ippolito, G
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (01) : 11 - 17
  • [8] Effect of tuberculosis on immune restoration among HIV-infected patients receiving antiretroviral therapy
    Ghebremichael, Musie
    Habtemicael, Semere
    [J]. JOURNAL OF APPLIED STATISTICS, 2018, 45 (13) : 2357 - 2364
  • [9] Outcomes of HIV-infected children with tuberculosis who are started on antiretroviral therapy in Malawi
    Bong, C-N.
    Chen, S. C. C.
    Jong, Y-J.
    Tok, T-S.
    Hsu, C-F.
    Schouten, E. J.
    Makombe, S. D.
    Yu, J. K-L.
    Harries, A. D.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2007, 11 (05) : 534 - 538
  • [10] Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance
    Stein, MD
    Urdaneta, ME
    Clarke, J
    Maksad, J
    Sobota, M
    Hanna, L
    Markson, LE
    [J]. JOURNAL OF ADDICTIVE DISEASES, 2000, 19 (01) : 85 - 94